{
  "id": "33cf2a13ceb3ded2",
  "title": "STAT+: Startup Altido Therapeutics pursues CAR-T for glioblastoma tumors",
  "description": "Glioblastoma is almost always fatal. Altido Bio is trying to commercialize a CAR-T cell therapy that has shown rare promise.",
  "content": "Glioblastoma is almost always fatal. Altido Bio is trying to commercialize a CAR-T cell therapy that has shown rare promise.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/28/gene-therapy-nick-leschly-startup-altido-therapeutics-targets-glioblastoma/?utm_campaign=rss",
  "published_at": "2026-01-28T09:30:00+00:00",
  "fetched_at": "2026-01-29T00:27:17.444867+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Startup Altido Therapeutics pursues CAR-T for glioblastoma tumors",
    "description": "Glioblastoma is almost always fatal. Altido Bio is trying to commercialize a CAR-T cell therapy that has shown rare promise.",
    "url": "https://www.statnews.com/2026/01/28/gene-therapy-nick-leschly-startup-altido-therapeutics-targets-glioblastoma/?utm_campaign=rss",
    "published": "2026-01-28T09:30:00+00:00",
    "source": "STAT"
  }
}